HUMAN ANTIBODIES TO HUMAN INTERLEUKIN 18 RECEPTOR ALPHA AND BETA

Provided are antibodies or fragments thereof having binding specificity to anti-IL-18 receptor alpha or beta. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory and autoimmune diseases are also provided.

Saved in:
Bibliographic Details
Main Authors MIERSCH, Shane, SIDHU, Sachedv, S, LIU, Shusu, WU, Donghui, HUANG, Haiming, PAN, Guohua James
Format Patent
LanguageEnglish
French
German
Published 28.04.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are antibodies or fragments thereof having binding specificity to anti-IL-18 receptor alpha or beta. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory and autoimmune diseases are also provided.
Bibliography:Application Number: EP20190823445